- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Saxagliptin – July 2015
Saxagliptin; 2.5 mg tablet, 28; 5.0 mg tablet, 28; Onglyza®
Last updated
1 November 2015